Retro Bio, a longevity startup backed by OpenAI CEO Sam Altman, is close to raising what could be one of the drug industry’s ...

Sam Altman’s longevity startup Retro Bio seeks to raise $5 billion valuation; Trump pollster advises House GOP on healthcare ...

Sam Altman's like all of us — he's aging. But a company he's backed wants it to stop. So could you pony up some cash at a $5 billion valuation?

Until recently, Google's efforts were viewed with skepticism after numerous high-profile (and embarrassing) setbacks. However ...

Amplitude CEO Spenser Skates praised Sam Altman's ability to get people to rally behind a "very ambitious vision" — and ...

Sam Altman approached rocket maker Stoke Space over potential multibillion-dollar investment as OpenAI CEO expands into space ...

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. OpenAI CEO Sam Altman has listed his sprawling oceanside compound on the Big Island of Hawaii for ...

OpenAI CEO Sam Altman said that he tried semaglutide "before it was cool" — and that it sent him to the hospital. Semaglutide is sold under brand names like Ozempic and Wegovy. Elon Musk has also said ...